REDUCED INTENSITY/NON-MYELOABLATIVE ALLOGRAFTING FOR HIGH RISK CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Giaccone, L. [1 ]
Sorasio, R. [1 ]
Fiore, F. [1 ]
Bergui, L. [1 ]
Resta, I [1 ]
Omede, P. [1 ]
Caltagirone, S. [1 ]
Massaia, M. [1 ]
Boccadoro, M. [1 ]
Bruno, B. [1 ]
机构：
[1] Univ Torino, Azienda Osped San Giovanni Battista, Div Ematol, Turin, Italy
来源：
HAEMATOLOGICA | 2008年 / 93卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P148
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [21] Reduced non-relapse mortality after reduced intensity conditioning in advanced chronic lymphocytic leukemia
    Schetelig, J
    Thiede, C
    Bornhäuser, M
    Schwerdtfeger, R
    Kiehl, M
    Beyer, J
    Kröger, N
    Hensel, M
    Scheffold, C
    Ho, AD
    Kienast, J
    Neubauer, A
    Zander, AR
    Fauser, AA
    Ehninger, G
    Siegert, W
    ANNALS OF HEMATOLOGY, 2002, 81 : S47 - S48
  • [22] Impact of rituximab on immunomodulation and survival after non-myeloablative allogeneic stem cell transplantation (NST) for chronic lymphocytic leukemia (CLL).
    Khouri, IF
    Lee, MS
    Saliba, RM
    Korbling, M
    McMannis, JD
    Keating, MJ
    Champlin, RE
    BLOOD, 2003, 102 (11) : 727A - 727A
  • [23] A non-myeloablative regimen with minimal non relapse mortality for allografting patients with Hodgkin's disease
    Kottaridis, P
    Milligan, D
    Chopra, R
    Craddock, C
    Mahendra, P
    Hunter, A
    Marsh, J
    Chakraverty, R
    Mills, A
    Kyriakou, C
    McKeag, N
    Hale, G
    Waldmann, H
    Linch, D
    Goldstone, A
    Mackinnon, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S66 - S66
  • [24] Non-myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia: A single institution experience
    Chakupurakal, G.
    Leitzke, S.
    Langerbeins, P.
    Schiller, J.
    Holtick, U.
    Theurich, S.
    James, R.
    Schneider, P.
    Hallek, M.
    Von Bergwelt-Baildon, M.
    Scheid, C.
    ONKOLOGIE, 2013, 36 : 60 - 60
  • [25] Non-myeloablative allogeneic stem cell transplantation for chronic lymphocytic leukaemia: a single institution experience
    Chakupurakal, G.
    Langerbeins, P.
    Leitzke, S.
    Schiller, J.
    Holtick, U.
    Theurich, S.
    James, R.
    Schneider, P.
    Hallek, M.
    von Bergwelt-Baildon, M.
    Scheid, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S128 - S128
  • [26] High rates of prolonged molecular remissions after tandem autologous non-myeloablative allografting in newly diagnosed myeloma
    Bruno, B.
    Ferrero, S.
    Drandi, D.
    Festuccia, M.
    Patriarca, F.
    Mordini, N.
    Cena, S.
    Barbero, D.
    Monitillo, L.
    Giaccone, L.
    Barbiero, S.
    Gallamini, A.
    Fanin, R.
    Passera, R.
    Palumbo, A.
    Boccadoro, M.
    Omede, P.
    Ladetto, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S200 - S201
  • [27] Non-myeloablative allografting for patients with myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML).
    Taussig, DC
    Cavenagh, JD
    Davies, AJ
    Oakervee, H
    Syndercombe-Court, D
    Kelsey, SM
    Barnett, MJ
    Rohatiner, A
    Lister, A
    BLOOD, 2002, 100 (11) : 409A - 410A
  • [28] Molecular monitoring of minimal residual disease after non-myeloablative allografting for multiple myeloma
    Bruno, B
    Ladetto, M
    Mordini, N
    Astolfi, M
    Rotta, M
    Cimolin, L
    Compagno, M
    Veneziano, L
    Aitoro, G
    Gallamini, A
    Storb, R
    Boccadoro, M
    BONE MARROW TRANSPLANTATION, 2003, 31 : S123 - S124
  • [29] Non-myeloablative peripheral blood stem cell transplantation for chronic myelogenous leukemia.
    Sloand, EM
    Childs, RW
    Greene, A
    Phang, S
    Young, NS
    Barrett, J
    BLOOD, 2000, 96 (11) : 783A - 783A
  • [30] Non-myeloablative transplant in patients with B-chronic lymphocytic leukemia (B-CLL):: Results of a prospective multicentre trial.
    Caballero, MD
    Martino, R
    León, A
    Urbano, A
    Sanz, G
    Sarrá, J
    Pérez, JA
    Canals, C
    Mateos, MV
    Sureda, A
    Sierra, J
    San Miguel, JF
    BLOOD, 2003, 102 (11) : 433B - 434B
12345